Steris (STE) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts STE Hot Sheet
Price: $236.60 --0%
Financial Fact:
Restructuring expenses: -56K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Restructuring expenses: -56K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Steris (NYSE: STE) reported Q3 EPS of $0.98, $0.04 better than the analyst estimate of $0.94. Revenue for the quarter came in at $618.7 million versus the consensus estimate of $617.35 million.
GUIDANCE:
Steris sees FY2016 EPS of $3.48-$3.55, versus the consensus of $3.51.
For earnings history and earnings-related data on Steris (STE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Legence Corp. (LGN) Misses Q2 EPS by 58c
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
